Abstract
Background New initiates on antiretroviral therapy (ART) are at high risk of treatment discontinuation, putting their health at risk. In low-resource settings, like Malawi, appropriate digital health applications must fit into local connectivity and resource constraints. Target users’ perspectives are critical for app usability, buy-in and optimization. We describe the formative stages of the design of a two-way text-based (2wT) system of tailored reminders and adherence messages for new ART initiates and share results from key informant interviews with HCWs focused on app usability and acceptability.
Methods Using a co-creation approach with clients, clinical, technical and evaluation teams and over app development, we held four informal user feedback sessions, a small pilot with 50 clients, and ten key informant (KIIs) to deepen our understanding of healthcare workers (HCWs) needs, acceptability and usability.
Results Formative research informed the design of interactive client-to-HCW communication, refining of the language and timing of weekly text blast motivational messages and tailored client-specific visit reminders. Informal feedback from HCW stakeholders also informed educational materials to enhance 2wT client understanding of how to report transfers, request visit date changes and ask questions related to their visits. In KII, HCWs noted their appreciation for the co-creation process, believing that the participatory HCD process and responsive design team enabled the development of a highly acceptable and usable 2wT digital tool. HCWs also suggested future improvements to promote inclusion of clients of varying literacy levels and economic backgrounds as well as integrating with other health platforms to improve uptake of 2wT.
Conclusions Inclusion of HCWs increased perceptions of app usability and acceptability among HCWs. HCWs believe that 2wT will improve on-time ART visit attendance and provide valuable early retention in care support. The co-creation approach appears successful in designing an app that will meet HCW needs and, therefore, support client adherence to visits.
Author Summary People starting antiretroviral treatment (ART) are at risk of poor or non-adherence which could lead to treatment failure or drug resistance, putting their health at risk. To help improve client adherence and, therefore, client outcomes, healthcare workers and healthcare systems need user-centred digital innovations that are appropriate for low- resource settings. Using a co-creation approach between the clients, clinical, technical, and evaluation teams, we designed, developed, and optimized a two-way text-based (2wT) system of tailored reminders and motivation messages for new ART initiates at Lighthouse Trust’s public ART clinic in Lilongwe, Malawi. The application leveraged the open-source, Community Health Toolkit, and was designed based on evidence of previous 2wT success in client engagement. We describe the formative stages of app co-design and share results from key informant interviews with HCWs focused on app usability and acceptability. We detail findings on the 2wT system design, perceived strengths, weaknesses, and recommendations for improvement to inform continued optimization for scale up. Overall, the co-creation approach appears successful in designing an app that will meet HCW needs and, therefore, support client adherence to visits.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research reported in this publication was supported by the Fogarty International Center of the National Institutes of Health (https://www.fic.nih.gov/) under Award Number R21TW011658 (PIs: CF & HT). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The parent study, including the usability and acceptability components, was reviewed and approved by the University of Washington and the Malawi National Health Sciences Research Committee. Participants in KIIs provided written informed consent. No other identifiers were produced nor utilized for formative data analysis in phases one or two.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Complete transcripts contain data that is sensitive or includes identifying information. The edited transcripts will be available on a case by case basis after reviewing all materials for any potentially identifying details. Interested researchers may contact the corresponding author, CF, at cfeld{at}uw.edu for copies of the transcripts. Or, researchers could also contact Jane Edelson jedelson{at}uw.edu, Regulatory Specialist at the UW, for access to the transcripts. Data described in the manuscript, code book, and analytic code will be made available upon request and completion of a relevant data-sharing agreement.
